Apr 07, 2016 7:05am EDT Immunovaccine and Leidos Join Forces to Develop a Zika Virus Vaccine Candidate
Mar 03, 2016 9:00am EST Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform
Jan 11, 2016 7:05am EST Immunovaccine Announces U.S. FDA, Health Canada Clearance to Initiate Phase 1b Clinical Trial for DPX-Survivac in Combination with Incyte's IDO1 Inhibitor Epacadostat in Recurrent Ovarian Cancer
Dec 17, 2015 7:05am EST Immunovaccine Publishes Findings Unique to DepoVax(TM) Technology on Potential of MRI Scans to Predict and Optimize Cancer Vaccine Response
Dec 02, 2015 7:05am EST Immunovaccine's DPX-Survivac Induces an Immune Response in Diffuse Large B Cell Lymphoma
Nov 12, 2015 5:05pm EST Immunovaccine Announces Financial Results for Quarter Ended September 30, 2015
Oct 29, 2015 7:05am EDT Immunovaccine's Vaccine Candidate for Respiratory Syncytial Virus Is Well Tolerated in Volunteers in Phase 1 Clinical Trial